Novel Automated Blood Separations Validate Whole Cell Biomarkers

BACKGROUND: Progress in clinical trials in infectious disease, autoimmunity, and cancer is stymied by a dearth of successful whole cell biomarkers for peripheral blood lymphocytes (PBLs). Successful biomarkers could help to track drug effects at early time points in clinical trials to prevent costly...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, Douglas E., Wang, Limei, Ban, Liqin, Okubo, Yoshiaki, Kühtreiber, Willem M., Leichliter, Ashley K., Faustman, Denise L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142167/
https://www.ncbi.nlm.nih.gov/pubmed/21799852
http://dx.doi.org/10.1371/journal.pone.0022430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142167/
https://www.ncbi.nlm.nih.gov/pubmed/21799852
http://dx.doi.org/10.1371/journal.pone.0022430

Ejemplares similares